Health
Phase 3 trial: New biologic therapy improves outcomes in adults, adolescents with severe asthma – News-Medical.Net
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency…
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference. NAVIGATOR (NCT03347279) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial.
Tezepelumab offers new therapeutic opportunities for patients…
-
General12 hours agoWondering about winter | The Spectator Australia
-
Noosa News20 hours agoOz Lotto’s $70 million jackpot won by Queensland syndicate – but not all of the winners know yet
-
Noosa News18 hours agoMan charged with murder after wife found dead in suspicious house fire near Toowoomba
-
Noosa News17 hours agoCameron Hunt, 45, charged with murder after body of his wife Louise Hunt found inside their Geham home just outside Toowoomba